Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Transforming growth factor β (TGF-β) isoforms are secreted as inactive complexes formed through noncovalent interactions between the bioactive TGF-β entity and its N-terminal latency-associated peptide prodomain. Extracellular activation of the latent TGF-β complex is a crucial step in the regulation of TGF-β function for tissue homeostasis. We show that the fibrinogen-like (FBG) domain of the matrix glycoprotein tenascin-X (TNX) interacts physically with the small latent TGF-β complex in vitro and in vivo, thus regulating the bioavailability of mature TGF-β to cells by activating the latent cytokine into an active molecule. Activation by the FBG domain most likely occurs through a conformational change in the latent complex and involves a novel cell adhesion–dependent mechanism. We identify α11β1 integrin as a cell surface receptor for TNX and show that this integrin is crucial to elicit FBG-mediated activation of latent TGF-β and subsequent epithelial-to-mesenchymal transition in mammary epithelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · cited 1×
“1016/S0092-8674(00)80545-0 were determined by the comparative threshold cycle method with the Gapdh gene as a reference (Schmittgen and Livak, 2008).”
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“Indeed, several ECM molecules have been shown to induce the epithelial-to-mesenchymal transition (EMT), a cell process allowing conversion of polarized, adherent epithelial cells into motile, mesenchymal-like cells (Thiery et al., 2009).”
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · cited 1×
“Matrix molecules can also interact with cell–surface growth factor receptors or sequester growth factors in the ECM and activate them when needed (Hynes, 2009).”
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128 · cited 1×
“This complex then translocates into the nucleus and binds to the chromatin to regulate TGF-–responsive genes (Massagué, 2012).”
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Likewise, adenovirus-mediated overexpression of Smad7, a natural inhibitor of Smad signaling (Nakao et al., 1997), impaired both TGF-1– and FBG-induced phosphorylation of Smad2 (Fig.”
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793 · cited 3×
“…cotransfected with the pGL3-basic reporter plasmid (Promega) encoding firefly luciferase under the control of TGF-–responsive elements ((CAGA)9-Luc; Dennler et al., 1998) together with the phRLCMV vector (Promega) encoding Renilla luciferase under the control of the cytomegalovirus ubiquitous…”
InfluentialInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634 · cited 2×
“SB431542, a small molecular weight inhibitor of the TGF- (TRI), Activin (ALK-4), and Nodal (ALK-7) type I receptors (Inman et al., 2002), was purchased from Sigma-Aldrich.”
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346 · cited 2×
“Although some RGD-dependent integrins have been shown to mediate a conformational change in the latent complex, causing bioactive TGF- to be exposed to cells (Munger et al., 1999; Asano et al., 2005, 2006; Wipff et al., 2007), we found that FBG-mediated TGF- activation does not require those integrins.”
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174 · cited 1×
“TSP-1 is the only matrix molecule described so far to bind and activate latent TGF- in vitro (Schultz-Cherry and Murphy-Ullrich, 1993; Schultz-Cherry et al., 1994) and in vivo (Crawford et al., 1998).”
Cited by
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
“By the way, FBG domain on tenascin-X, a member of tenascins, supports its mechanic interaction with TGF-β, then induce maturation of TGF-β, highlights the potential role of FBG domain on other tenascins in TGF-β maturation [250, 593].”
BackgroundTGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 458
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
“These interactions may deform LAP and also rely on cell adhesion via integrin a11b1 to promote activation (Alcaraz et al. 2014).”
BackgroundThe interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
“α11β1 GFOGER on fibrous collagen (245, 246) Overexpression leads to phenotype resembling cardiac fibrosis (260), can liberate TGF-β from LAP via TNX (257) Granulation tissue (scar)”
BackgroundRevisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
“Interestingly, two different matricellular proteins, TSP1 and tenascin-X can convert latent TGF-β to its biologically active form, indirectly regulation ECM expression (Schultz-Cherry and Murphy-Ullrich, 1993; Alcaraz et al., 2014).”
BackgroundTenascin-C and integrins in cancer
Yoshida, T., Akatsuka, T., & Imanaka-Yoshida, K. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1008332 · Cited by 178
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Tenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132
“The regulation of cell plasticity by the central region of the glycoprotein (FNIII repeats) might provide the first clue of a cell function controlled through a cell adhesion-modulating activity for TN-X.”
BackgroundResultInfluentialSelf-citationZuliani-Alvarez, L., Marzeda, A. M., Deligne, C., Schwenzer, A., McCann, F. E., Marsden, B. D., Piccinini, A. M., & Midwood, K. S. (2017) · Nature Communications · doi:10.1038/s41467-017-01718-7 · Cited by 115
Tenascin-X Mediates Flow-Induced Suppression of EndMT and Atherosclerosis
Liang, G., Wang, S., Shao, J., Jin, Y., Xu, L., Yang, Y., Günther, S., Wang, L., & Offermanns, S. (2022) · Circulation Research · doi:10.1161/circresaha.121.320694 · Cited by 123
Role of tenascins in the ECM of gliomas
Brösicke, N., & Faissner, A. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2014.1000071 · Cited by 111
“Found in many adult tissues TN-X plays a crucial role in the modulation of cell-matrix communication.(145) By interacting with numerous ECM molecules like collagens(148,149) or decorin(150) it is involved in the adhesion and spreading of cells.”
BackgroundThe Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
Gerarduzzi, C., Hartmann, U., Leask, A., & Drobetsky, E. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-18-2098 · Cited by 107
Agonists and Antagonists of TGF-β Family Ligands
Chang, C. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021923 · Cited by 94
The emerging roles of eosinophils in mucosal homeostasis
Shah, K., Ignácio, A., McCoy, K. D., & Harris, N. L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0281-y · Cited by 103
Li, Y., Fan, W., Link, F., Wang, S., & Dooley, S. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2021.100397 · Cited by 79
Collagen Assembly at the Cell Surface: Dogmas Revisited
Musiime, M., Chang, J., Hansen, U. J., Kadler, K. E., Zeltz, C., & Gullberg, D. (2021) · Cells · doi:10.3390/cells10030662 · Cited by 89
“have suggested a role for TN-X in breast cancer progression through TGF-β activation and epithelial-to-mesenchymal transition (EMT), which is suggested to be dependent on α11β1 integrin [64].”
BackgroundInsights into the key roles of epigenetics in matrix macromolecules-associated wound healing
Piperigkou, Z., Götte, M., Theocharis, A. D., & Karamanos, N. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.008 · Cited by 77
Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
Morissette, R., Chen, W., Perritt, A. F., Dreiling, J. L., Arai, A. E., Sachdev, V., Hannoush, H., Mallappa, A., Xu, Z., McDonnell, N. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2232 · Cited by 68
“Co-Immunoprecipitation Coimmunoprecipitation experiments were conducted according to Alcaraz, et al (16) Briefly, whole cell lysate (equivalent volume of 10 ug protein according to a BCA assay) from dermal fibroblasts was lysed as above and subjected to immunoprecipitation using the Dynabeads Protein G Immunoprecipita…”
BackgroundMethodInfluentialZuliani‐Alvarez, L., & Midwood, K. S. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0599 · Cited by 74
“This mechanism is dependent on the binding of the FBG domain to a11b1 integrin in the cell surface.(95)”
BackgroundTenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases
Matsumoto, K., & Aoki, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609752 · Cited by 64
“They also showed that the FBG-related domain-mediated TGF-b activation elicits the TGF-b/Smad signaling pathway and causes epithelial-mesenchymal transition (EMT) in epithelial cells (56).”
BackgroundTransforming Growth Factor-Beta Polymorphisms and Serum Level in the Development of Osteosarcoma
Xu, S., Yang, S., Sun, G., Huang, W., & Zhang, Y. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2527 · Cited by 57
“Conversely, TGF-b has also emerged as a key player in the maintenance of self-renewal and stemness, ensuring that embryonic and somatic stem cells retain their undifferentiated state (Alcaraz et al. , 2014; Fouad et al. , 2014).”
Tenascins in fibrotic disorders—from bench to bedside
Kasprzycka, M., Hammarström, C., & Haraldsen, G. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994901 · Cited by 56
Alcaraz, L. B., Mallavialle, A., David, T., Derocq, D., Delolme, F., Dieryckx, C., Mollévi, C., Boissière‐Michot, F., Simony-Lafontaine, J., du Manoir, S., et al. (2021) · Theranostics · doi:10.7150/thno.58254 · Cited by 59
“To identify the SPARC domain(s) involved in these functions, we produced FL SPARC and its various cleaved fragments in mammalian cells and purified them, as previously described [52, 53] (Figure 7A, Table S2).”
Self-citationCichon, M. A., & Radisky, D. C. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.972788 · Cited by 60
Design principles of tissue organisation: How single cells coordinate across scales
Zinner, M., Lukonin, I., & Liberali, P. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.07.004 · Cited by 55
Ballesteros, Á., Mentink‐Kane, M. M., Warren, J., Kaplan, G. G., & Dveksler, G. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597518 · Cited by 50
“Several studies have shown that the LSKL peptide competes with TSP-1 and inhibits the ability of this protein to trigger activation of latent TGF- 1 (26, 28).”
BackgroundChen, W., Perritt, A. F., Morissette, R., Dreiling, J. L., Bohn, M.-F., Mallappa, A., Xu, Z., Quezado, M., & Merke, D. P. (2016) · Human Mutation · doi:10.1002/humu.23028 · Cited by 45
“TNX has been shown to modulate cell adhesion [Alcaraz et al., 2014]; therefore, examining TNX’s signaling function in the context of its matricellular properties opens the door for a new means of studying this ECM glycoprotein.”
BackgroundLatent TGF-β Activation Is a Hallmark of the Tenascin Family
Aubert, A., Mercier‐Gouy, P., Aguero, S., Berthier, L., Liot, S., Prigent, L., Alcaraz, L. B., Verrier, B., Terreux, R., Moali, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613438 · Cited by 47
Self-citationKoskimäki, J., Zhang, D., Li, Y., Saadat, L., Moore, T., Lightle, R., Polster, S. P., Carrión‐Penagos, J., Lyne, S. B., Zeineddine, H. A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0789-0 · Cited by 45
“Similarly, Tnxb was highly upregulated, which encodes tenascin X, which has been shown to promote epithelialmesenchymal transformation by activating latent Tgfβ [3].”
BackgroundGao, Y., Duran, S., Lydon, J. P., DeMayo, F. J., Burghardt, R. C., Bayless, K. J., Bartholin, L., & Li, Q. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.125146 · Cited by 47
Self-citationJana, S., Zhang, H., Lopaschuk, G. D., Freed, D. H., Sergi, C. M., Kantor, P. F., Oudit, G. Y., & Kassiri, Z. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010427 · Cited by 37
“This can occur through the interaction of the latent complex (latency-associated peptide–TGF-b) with integrins,(9) glycoproteins such as thrombospondin-1,(27) or tenascin-x.(28) TGF-b1 has also been reported to regulate the expression of small leucine-rich proteoglycans(29) and to suppress the expression A”
BackgroundZhu, L., Liu, L., Wang, A., Liu, J., Huang, X., & Zan, T. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.05.001 · Cited by 42
Viloria, K., & Hill, N. J. (2016) · BioMolecular Concepts · doi:10.1515/bmc-2016-0004 · Cited by 36
Saika, S., Yamanaka, O., Okada, Y., & Sumioka, T. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2014.12.015 · Cited by 35
Vesicoureteral reflux and the extracellular matrix connection
Tokhmafshan, F., Brophy, P. D., Gbadegesin, R. A., & Gupta, I. R. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3386-5 · Cited by 30
“The fibrosis is mediated by myofibroblasts that appear to arise from a diverse range of precursor cell types including epithelial cells, endothelial cells, smooth muscle cells, and pericytes, and in response to inflammatory cytokines such as transforming growth factor-β1 (TGF-β1) [15] [16].”
InfluentialSumioka, T., Iwanishi, H., Okada, Y., Miyajima, M., Ichikawa, K., Reinach, P. S., Matsumoto, K., & Saika, S. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00576-8 · Cited by 27
Tenascin-X—Discovery and Early Research
Miller, W. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612497 · Cited by 26
“TNX has functions beyond EDS (55); it promotes epithelialmysenchymal transitions in development (56), and may be associated with tumor invasion (57–59).”
BackgroundYokosaki, Y., & Nishimichi, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312794 · Cited by 27
Identification of the growth factor–binding sequence in the extracellular matrix protein MAGP-1
Broekelmann, T. J., Bodmer, N. K., & Mecham, R. P. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010540 · Cited by 24
Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta
Imanaka‐Yoshida, K., & Matsumoto, K. (2018) · Annals of Vascular Diseases · doi:10.3400/avd.ra.17-00118 · Cited by 22
Hashimoto, K., Kajitani, N., Miyamoto, Y., & Matsumoto, K. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.025 · Cited by 26
Wang, K., Zhao, S., Zhang, Q., Yuan, J., Liu, J., Ding, X., Song, X., Lin, J., Du, R., Zhou, Y., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0496-x · Cited by 24
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling
Liang, G., Lv, X., Huang, W., Jin, Y., Roquid, K. A., Kawase, H., & Offermanns, S. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.321067 · Cited by 22
Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome
Okuda‐Ashitaka, E., & Matsumoto, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1107787 · Cited by 22
“Initially, we speculated that TGF-β and TNX-FBG with integrin α11β1 are involved in the induction of COL1A1 expression since interaction of the TNXFBG domain and TGF-β was reported previously (Alcaraz et al., 2014) and TGF-β is a well-known central mediator of fibrosis (Dewidar et al.”
BackgroundMackenroth, L., Fischer‐Zirnsak, B., Egerer, J., Hecht, J., Kallinich, T., Stenzel, W., Spors, B., von Moers, A., Mundlos, S., Kornak, U., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37547 · Cited by 18
“One important function of tenascin-X seems to be the regulation of TGF-b activity in concert withmyriads of other ECMproteins, among themalso collagen type 1 [Alcaraz et al., 2014].”
BackgroundGenome-Wide Open Chromatin Methylome Profiles in Colorectal Cancer
Ishak, M., Baharudin, R., Rose, I. M., Sagap, I., Mazlan, L., Azman, Z. A. M., Abu, N., Jamal, R., Lee, L., & Mutalib, N. A. (2020) · Biomolecules · doi:10.3390/biom10050719 · Cited by 18
“It was first implicated in Ehlers-Danlos syndrome [45], but its role in malignancy has also been established in several cancers including nasopharyngeal [46] and mesothelioma [47], most possibly by promoting the epithelial-to-mesenchymal transition (EMT) to activating latent transforming growth factor-β [48].”
BackgroundPatient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics
Doherty, E. L., Aw, W. Y., Warren, E. C., Hockenberry, M. A., Whitworth, C. P., Krohn, G., Howell, S., Diekman, B. O., Legant, W. R., Nia, H. T., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.015 · Cited by 21
Vargas, A. C., Gray, L.-A., White, C. L., Maclean, F. M., Grimison, P., Ardakani, N. M., Bonar, F., Algar, E. M., Cheah, A. L., Russell, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79648-6 · Cited by 21
A method for quantification of serum tenascin-X by nano-LC/MS/MS
Yamada, K., Watanabe, A., Takeshita, H., & Matsumoto, K. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.022 · Cited by 17
Pathogenic mechanisms in genetically defined Ehlers–Danlos syndromes
Syx, D., & Malfait, F. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.06.001 · Cited by 19
Loss of tenascin X gene function impairs injury‐induced stromal angiogenesis in mouse corneas
Sumioka, T., Iwanishi, H., Okada, Y., Nidegawa, Y., Miyajima, M., Matsumoto, K., & Saika, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13397 · Cited by 15
“For example, TNX reportedly activates the latent form of endogenous TGFb1 and accelerates epithelialmesenchymal transition in cell culture [35, 36].”
BackgroundA potential contribution of tenascin-X to blood vessel formation in peripheral nerves
Sakai, H., Yokota, S., Kajitani, N., Yoneyama, T., Kawakami, K., Yasui, Y., & Matsumoto, K. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.06.003 · Cited by 16
“A recent study showed that TNX triggered epithelial-to-mesenchymal transition in epithelial cells by stimulating transforming growth factor-β signaling pathway (Alcaraz et al., 2014).”
Wang, B., Ji, G., Naeem, H., Wang, J., Kantharidis, P., Powell, D., & Ricardo, S. D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01755 · Cited by 11
“Tenascin XB (TNXB), which could be linked to the activation of TGF-β1 (Alcaraz et al., 2014), was the only DE-gene that was downregulated and hypermethylated (Table 9).”
BackgroundYao, H., Shi, H., Jiang, C., Fan, M., Zhang, Y., Qian, W., & Lin, R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01311-0 · Cited by 9
“B), while the protein levels of TGF-β1, TGF-β receptor I (TGF-βR1), and the phosphorylation levels of PI3K and AKT had no significant changes ( p > 0.05, Fig.”
BackgroundInfluentialTenascins and osteopontin in biological response in cornea
Sumioka, T., Matsumoto, K., Reinach, P. S., & Saika, S. (2023) · The Ocular Surface · doi:10.1016/j.jtos.2023.05.005 · Cited by 11
Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet
YAMAGUCHI, S., Kawakami, K., Satoh, K., Fukunaga, N., Akama, K., & Matsumoto, K. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7052 · Cited by 11
“Alcaraz et al (18) reported that TNX interacts with the latent TGF-β complex via the C-terminal fibrinogen‑like (FBG) domain of TNX, regulating the activation of the latent TGF-β form into an active molecule.”
BackgroundInfluentialHui, L., Zhang, J., Ding, X., Guo, X., & JANG, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7083 · Cited by 9
“It is able to promote EMT by activating latent transforming growth factor-β (33).”
Nakatake, M., Kurosaki, H., & Nakamura, T. (2023) · Cancer Science · doi:10.1111/cas.16032 · Cited by 8
“53 Tnxb is involved in EMT transition, 54 and Prph is involved in neurite growth and enterovirus-A71 infection.”
BackgroundKulebyakina, M., Basalova, N. A., Butuzova, D. A., Arbatsky, M. S., Chechekhin, V. I., Kalinina, N., Tyurin‐Kuzmin, P. A., Kulebyakin, K. Y., Klychnikov, O. I., & Efimenko, A. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010290 · Cited by 11
Chen, J., Zeng, Q., Wang, X., Xu, R. C., Wang, W., Huang, Y., Sun, Q., Yuan, W., Wang, P., Chen, D., et al. (2024) · eLife · doi:10.7554/elife.93087 · Cited by 12
Measurement of Serum Tenascin-X in Joint Hypermobility Syndrome Patients
Yamada, K., Watanabe, A., Takeshita, H., Fujita, A., Miyake, N., Matsumoto, N., & Matsumoto, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00168 · Cited by 7
Cardenas, S. M. C., El-Kaissi, S., Jarad, O., Liaqat, M., Korbonits, M., & Hamrahian, A. H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa077 · Cited by 8
“It is involved processes related to cell adhesion, migration, and stabilization of collagen fibers, including types I, III, V, VII, and IX [22].”
BackgroundMatsumoto, K., Kawakami, K., Yamada, K., & Takeshita, H. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12846 · Cited by 9
“Alcaraz et al (26) demonstrated that the FG‑related domain of TNX activates latent TGF‑β1 via integrin α11β1 as a novel receptor of TNX, thereafter leading to activation of the TGF‑β/Smad signaling pathway followed by epithelial‑mesen‑ chymal transition (EMT) in epithelial cells (6).”
BackgroundZhang, Y., Chen, B., Xie, X., Zhou, Y., Qian, Q., & Jiang, C.-Q. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i7.717 · Cited by 6
Role of Matricellular Proteins in Endothelial Cell Inflammation and Atherosclerosis
Aithabathula, R. V., Kumar, S., & Singla, B. (2025) · Antioxidants · doi:10.3390/antiox14111338 · Cited by 5
“Further, TN-X induces inflammation via activation of TGF-β signaling and interaction with cell surface integrins ( α 11 β 1), altering tissue dynamics and immune responses [339,347,348].”
Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?
Zeltz, C., Navab, R., Kusche‐Gullberg, M., Tsao, M., & Gullberg, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_4 · Cited by 6
Transcriptomic characterization of transitioning cell types in the skin of Atlantic salmon
Daniels, R. R., Salisbury, S. J., Sveen, L. R., Villamayor, P. R., Taylor, R. S., Vaadal, M., Tengs, T., Krasnov, A., Monaghan, S. J., Ballantyne, M., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02196-w · Cited by 7
“Cluster 3 in PHATE was marked as fibroblast with markers such as tenascinb (ENSSSAG00000078781) [57] and htra1b ( ENSSSAG00000051286) [35].”
The Role of Non-collagenous Proteins and Other Matrix Molecules in Vertebrate Mineralization
Shapiro, I. M., & Landis, W. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-34304-9_8 · Cited by 7
Expression of the Extracellular Matrix Protein Tenascin-C Varies During Lactation
Qin, W., Dasgupta, S., Mukhopadhyay, N. D., & Sauter, E. R. (2016) · Breastfeeding Medicine · doi:10.1089/bfm.2015.0153 · Cited by 3
Radler, C. N., Wang, T., LeGate, J. F., Crone, L., Deo, P., Wortley, J., Moore, P., Bryant, G., Smitherman, K., & Sathyamoorthy, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136535 · Cited by 2
“Furthermore, one study suggests that FNIII and FBG domains utilize distinct signaling pathways to regulate EndMT [11,43].”
Dill, M. N., Turner, Z. R., Kapuscinska, P. W., Heiden, K. D., Basso, K. B. G., Simmons, C. S., & Moore, E. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00810 · Cited by 1
Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?
Zeltz, C., Navab, R., Lü, N., Kusche‐Gullberg, M., Tsao, M., & Gullberg, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_5 · Cited by 2
Characterisation of mesenchymal stromal cells in the skin of Atlantic salmonPreprint
Daniels, R. R., Salisbury, S. J., Sveen, L. R., Taylor, R. S., Vaadal, M., Tengs, T., Monaghan, S. J., Villamayor, P. R., Ballantyne, M., Peñaloza, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.23.581759 · Cited by 1
Tenascin-X and the pick of destiny
Short, B. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.2053iti3
Chen, J., Qinghe, Z., Wang, X., Xu, R. C., Wang, W., Huang, Y., Sun, Q., Yuan, W., Wang, P., Chen, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.11.570472
Chen, J., Qinghe, Z., Wang, X., Xu, R. C., Wang, W., Huang, Y., Sun, Q., Yuan, W., Wang, P., Chen, D., et al. (2024) · eLife · doi:10.7554/elife.93087.1
Ehlers-Danlos syndrome: From bedside to bench
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4557-7
Chen, J., Qinghe, Z., Wang, X., Xu, R. C., Wang, W., Huang, Y., Sun, Q., Yuan, W., Wang, P., Chen, D., et al. (2024) · eLife · doi:10.7554/elife.93087.2
Liot, S., Schmitter, C., Mercier‐Gouy, P., Kholti, N. E., Balas, J., Prigent, L., Aubert, A., Lethias, C., Chitty, J. L., Koch, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.07.635757
Self-citationYao, H., Shi, H., Jiang, C., Fan, M., Zhang, Y., Qian, W., & Lin, R. (2024) · Figshare · doi:10.6084/m9.figshare.24257594
Yao, H., Shi, H., Jiang, C., Fan, M., Zhang, Y., Qian, W., & Lin, R. (2023) · Figshare · doi:10.6084/m9.figshare.24257463
Bertrand‐Chapel, A. (2021) · theses.fr (ABES) · doi:10.70675/6f1078b7z94d3z4096z85a9z40b435cd6a59
Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency
Sappl, A., Sriramachandran, A. M., Lottspeich, C., Vill, K., Morak, M., Welp, A.-C., Dervishi, O., Bidlingmaier, M., Kunz, S. L., & Reisch, N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1797669
“Low levels of TNXB have been reported in fi ve different types of cancers to cause an upregulation of TGF-b 1-regulated genes (9, 10).”
Sumioka, T., Iwanishi, H., Jester, J. V., Joshi, R., Bradford, S. M., Yasuda, S., Miyajima, M., Okada, Y., Matsumoto, K., & Saika, S. (2026) · The Ocular Surface · doi:10.1016/j.jtos.2026.06.013
Unbiased Spatial Proteomics Uncovers Hepatic in Situ Regulation in Alcohol-Associated Hepatitis
Day, L. Z., Hernández‐Tejero, M., Jalan‐Sakrikar, N., Mokbul, M. I., Williams, S., Veličković, M., Kwon, Y., Call, D. H., Fulcher, J. M., Morgan, T. R. M., et al. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.06.001
Tenascin X and Tenascin C Serum Levels in Relation to Age and Cardiometabolic Risk Parameters
Baumgartner-Parzer, S. M., Fuhrberg, K., Wagenlechner, C., Schnait, F., Schmid, N., Bayerle‐Eder, M., Grimm, G., Vila, G., & Schernthaner-Reiter, M. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209180
“While these relationships could potentially be secondary to aging, cardiometabolic risk and atherosclerosis are linked to inflammation via endothelial dysfunction and vascular remodeling [19], and TNX was shown to mediate TGF-β function by regulating its bioavailability and activation [20].”
Metadata
- Authors
- Alcaraz, L. B., Exposito, J.-Y., Chuvin, N., Pommier, R. M., Cluzel, C., Martel, S., Sentis, S., Bartholin, L., Lethias, C., & Valcourt, U.
- Affiliations
- Lyon 1 Université (FR)
- Corresponding author
- Valcourt, Ulrich
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2014-05-12
- Volume
- 205
- Issue
- 3
- Pages
- 409-428
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC4018787
- OpenAlex
- W2041801047
- Cited by
- 94
- References
- 66
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 3 · 2021: 11 · 2020: 10 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 8
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- tenascin-X, epithelial-mesenchymal transition, latent TGF-beta activation, fibrinogen-like domain, cell adhesion, mammary epithelial cells, extracellular matrix, conformational change
- MeSH terms
- Animals, Cattle, Cell Adhesion, Epithelial Cells, Female, Humans, Mammary Glands, Animal, Phosphorylation, Protein Binding, Protein Conformation, Protein Precursors, Recombinant Proteins, Transfection, Signal Transduction, Integrins, Tenascin, RNA Interference, Receptors, Collagen, Mammary Glands, Human, Cell Line, Tumor, Mice, Smad Proteins, Transforming Growth Factor beta1, Protein Interaction Domains and Motifs, HEK293 Cells, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.